Skip to main content
. 2016 Oct 28;11(10):e0164076. doi: 10.1371/journal.pone.0164076

Table 3. Proportion of time in therapeutic range (%) for patients on different vitamin K antagonists*.

VKA therapy n (%) Mean SD Median Interquartile range
Warfarin 6513 (66.7) 55.4 28.4 60.8 35.7 to 77.6
Acenocoumarol 2345 (24.0) 52.9 23.7 54.7 37.4 to 70.4
Phenprocoumon 672 (6.9) 56.2 26.7 57.6 37.3 to 77.3
Other 231 (2.4) 59.2 28.1 65.6 38.9 to 80.4

*N = 9934; data missing for 173 patients.

SD, standard deviation; VKA, vitamin K antagonist.